glp-1 for alcohol use disorder Frontiers GLP-1 receptor agonists are promising
Description
Elizabeth McDonald, breast radiologist and co-director of the Breast Cancer Translational Research Group at Penn Medicine
These programs can cause treatment delays, expose patients to unsafe or unlicensed medicines, and create significant civil and criminal liability for health plans
Similarly, Yao et al
GLP-1 Receptor Agonist Medications: Interactions With Addiction Neurocircuitry
Nature Rev Disease Primers
More recently, the ASA along with multiple other specialist societies recommended that if patients do continue GLP-1s, they should be on a 24-hour liquid only diet prior to procedure
